Key Segments:
By Drug Type
-
Small Molecules
-
Biologics
-
Others
By Process
-
Target Identification & Validation
-
Hit-to-Lead Identification
-
Lead Optimization
-
Candidate Validation
-
Others
By Technology
-
High-Throughput Screening
-
Bioinformatics
-
Molecular Modeling & Simulation
-
Genomics
-
Proteomics
-
Others
By End User
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Academic & Research Institutes
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with approximately 41.27% of revenues in 2025.
Small Molecules dominated with approximately 59.41% of revenues in 2025.
The integration of artificial intelligence and machine learning across all drug discovery process stages, from target identification through candidate validation.
The drug discovery market was valued at USD 71.95 billion in 2025.
The drug discovery market is expected to grow at a CAGR of 9.29% from 2026 to 2035.